In MDSCs from colorectal cancer models, ALKBH5 downregulation elevated m6A and arginase-1 expression; whereas restoring ALKBH5 curtailed MDSC suppressive activity and protumor effects in vivo (92). The gene discussed is ALKBH5; the disease is colorectal cancer.